TR:NYSETootsie Roll Industries, Inc. Analysis
Data as of 2026-08-02 - not real-time
$39.02
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Tootsie Roll Industries sits near its 20‑day and 50‑day moving averages, with a bullish MACD crossover that suggests short‑term upside, yet the RSI hovers around the midpoint indicating no strong momentum. Volume is on a downtrend, and the stock is trading close to a clear resistance level while support sits a few dollars below, framing a narrow technical range. The company’s fundamentals show modest revenue growth, solid gross and operating margins, and a healthy cash position relative to a modest debt load, supporting a stable dividend that is covered comfortably by cash flow. However, forward earnings are projected negative, the forward PE is negative, and a discounted cash‑flow model values the firm at less than half the current market price, flagging a significant valuation gap. Recent analyst commentary downgraded the stock to a soft‑sell, citing higher cocoa input costs that squeezed margins and a premium valuation compared with peers.
The defensive consumer sector backdrop and low beta suggest limited market‑wide volatility exposure, but the stock’s 30‑day price swings remain high, and liquidity is constrained by decreasing volume. While the dividend appears sustainable, the overvalued price and earnings outlook temper enthusiasm, positioning the stock as a cautious hold for income‑focused investors rather than a growth play.
The defensive consumer sector backdrop and low beta suggest limited market‑wide volatility exposure, but the stock’s 30‑day price swings remain high, and liquidity is constrained by decreasing volume. While the dividend appears sustainable, the overvalued price and earnings outlook temper enthusiasm, positioning the stock as a cautious hold for income‑focused investors rather than a growth play.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- soft‑sell downgrade and premium valuation
- decreasing trading volume and proximity to resistance
- negative forward earnings outlook
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- stable dividend yield with low payout ratio
- defensive consumer‑staples positioning
- potential relief from cocoa cost pressures
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- strong brand portfolio and cash generation
- low debt and solid balance sheet
- persistent valuation gap limiting upside
Key Metrics & Analysis
Financial Health
Revenue Growth2.10%
Profit Margin13.55%
P/E Ratio31.0
ROE10.90%
ROA6.06%
Debt/Equity1.43
P/B Ratio3.1
Op. Cash Flow$138.5M
Free Cash Flow$63.7M
Technical Analysis
TrendNeutral
RSI51.8
Support$37.20
Resistance$40.90
MA 20$38.66
MA 50$38.46
MA 200$39.01
MACDBullish
VolumeDecreasing
Fear & Greed Index92.88
Valuation
Fair Value$13.97
GradeOvervalued
TypeValue
Dividend Yield0.92%
Risk Assessment
Beta-0.21
Volatility33.30%
Sector RiskLow
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.